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ABSTRACT
The removal of biofilm and mineralized deposits from the tooth
surface are the fundamental aspects of periodontal therapy.
Using antimicrobial agents to treat periodontitis without
disruption of the biofilm ultimately results in treatment failures.
It is difficult to maintain therapeutic concentrations at the target
sites and target organisms may develop resistance to drugs.
Photodynamic therapy (PDT) is a mechanism which destroys
target cells by reactive oxygen species produced by
photosensitizing compounds and light of an appropriate
wavelength. The advantage of this new approach includes rapid
bacterial elimination, minimal chance of resistance development
and safety of adjacent host tissue and normal microflora. Thus,
the available knowledge of photodynamic therapy should
encourage a more clinically oriented application of this technique.
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INTRODUCTION
Following history, therapeutic use of ultraviolet light begins
in 1900 when Raab1 reported that combination of archidine
orange and ultraviolet light could destroy living organisms
(paramecium). In 1920s Policard2 noted that tumor tissue
was inherently more fluorescent than healthy tissue. In 1950s
Ronchese3 attempted to activate endogenous fluorescent
molecules in tumor tissue to delineate its boundaries more
accurately. In the 1960s Winkelman4 used synthetic
porphyrins (tetraphenylporphines) to detect tumor tissue.
Throughout 20th century few attempts were made to treat
tumor tissues mainly with nonporphyrin photosensitizers.
In the 1970s Dougherty rediscovered that fluorescein
diacetate could photodynamically destroy T A-3 cells
in vitro.5 Dougherty then began treating tumor-bearing
animals with fluorescein and found that it could work as a
photosensitizer.6 In 1976; Weisshaupt et al7 identified the
cytotoxic product of photochemical reaction to be singlet
oxygen. Porphyrin photosensitizers were then examined as
they are efficient singlet oxygen generators and have
absorption maxima in the red portion of electromagnetic
spectrum. After several years spent isolating and identifying
the active fractions of hematoporphyrin derivatives (HpDs),
a purified version name Photofrin was produced. In following
years Photofrin was approved for use in United States against
early and late stage lung cancers and esophageal cancers
and dysplasia. Photodynamic therapy (PDT) has been used
against bladder cancers, brain cancers, breast cancers,
gynecological malignancies and colorectal cancers.8
Photodynamic therapy (PDT) is a medical treatment
modality that utilizes light to activate a photosensitizing
agent (photosensitizer) in the presence of oxygen.
Photodynamic therapy (PDT), also known as photoradiation
therapy, phototherapy, or photochemotherapy, involves the
use of a photoactive dye (photosensitizer) that is activated
by exposure to light of a specific wavelength in the presence
of oxygen.8
Mechanism of Action (Fig. 1)
Photodynamic therapy comprises of three components:
Light, photosensitizer and oxygen. The exposure of the
photo sensitizer to light results in the formation of oxygen
species, such as singlet oxygen and free radicals, causing
localized photo damage and cell death. Clinically, this
reaction is cytotoxic and vasculotoxic.8
Depending on the type of agent, photosensitizers may
be injected intravenously, ingested orally or applied
topically.8
When administered to patients upon irradiation with
specific wavelength photosensitizer goes to low-energy
ground state to excited singlet state. Subsequently then goes
to ground state with decay and there is emission of
fluorescence or goes directly to high level- triplet state. The
triplet state can react with endogenous oxygen to produce
singlet oxygen and other radical species, causing a rapid
and selective destruction of the target tissue.9
 There are two mechanisms by which the triplet-state
photosensitizer can react with biomolecules. First
10.5005/jp-journals-10026-1019
Fig. 1: Mechanism of action
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mechanism involves electron/hydrogen transfer directly
from the photosensitizer, producing ions or electron/
hydrogen removal from a substrate molecule to form free
radicals. These radicals react rapidly with oxygen, resulting
in the production of highly reactive oxygen species
(superoxide, hydroxyl radicals and hydrogen peroxide). The
other mechanism produces the electronically excited and
highly reactive state of oxygen known as singlet oxygen. In
PDT, it is difficult to distinguish between the two reactions
mechanisms. A contribution from both types of processes
indicates that the mechanism of damage is dependent on
both oxygen tension and photosensitizer concentration.9
Types of Photosensitizers
In antimicrobial photodynamic therapy, various types of
photosensitizers are used (Table 1).
According through their evolution again they are
subdivided into first, second and third generation photo-
sensitizers (Table 2). Currently, only four photosensitizers
are commercially available: Photofrin, ALA, VisudyneTM
(Verteporfin) and Foscan.9,10
Laser Sources
Human tissue transmits red light efficiently, and the longer
activation wavelength of the photosensitizer results in deeper
light penetration. Consequently, most photosensitizers are
activated by red light between 630 and 700 nm.11
There are three light systems for the photodynamic
therapy:12
1. Diode laser systems.
2. Noncoherent light sources: Preferred for treatment of
larger areas and include tungsten filament, quartz
halogen, xenon arc, metal halide and phosphor-coated
sodium lamps.
3. Nonlaser light sources include light emitting diodes
(LED).
APPLICATION OF PHOTODYNAMIC THERAPY
Photodynamic therapy has been applied in many oral
conditions like superficial precancerous oral lesions, such
as oral leukoplakia, oral erythroleukoplakia, oral verrucous
hyperplasia, lichen planus as well various bacterial, fungal
and viral infections of the oral cavity.34
 Use of photodynamic therapy in periodontitis and peri-
implantitis:
As an Adjunct to Scaling and Root Planning
Research on plaque development has shown that oral
bacteria colonize nonshedding hard surfaces and shedding
soft tissue surfaces. The physical and morphologic
characteristics of these surfaces create different ecosystems
or niches with distinct bacterial plaque.13
Wide ranges of persistent human infections are due to
microbial biofilms. Microorganisms grow in biofilms stuck
to a solid surface where they multiply and form micro
colonies embedded in extracellular polymeric matrix, which
includes water and nutrient channels. Periodontal diseases
result from accumulation of subgingival bacterial biofilms
on tooth surfaces. There is reduced susceptibility of these
biofilms to antimicrobial agents.15,16
Mechanical removal of the periodontal biofilms is
currently the most frequently used method of periodontal
disease treatment.14
Various studies have been done with combination anti-
microbial therapy which has shown significant improvement
in clinical as well as microbiological aspects.17-21
The combination of systematically administered
amoxicillin and metronidazole for the treatment of certain
periodontal infections has been quite effective.19-21
But certain biofilm species exhibit several antibiotic-
resistance mechanisms, such as quorum sensing.22,23
Recently, a new type of noninvasive phototherapy for
bacterial elimination, called photodynamic therapy, has been
introduced, which uses low-level laser.24,25 Unlike high-level
lasers, photodynamic therapy can selectively target the
bacteria without potentially damaging the host tissues.26,27
As depicted in Table 3. Various studies were done with
different time period like 3 and 6 months and they used clinical
Table 2: Generations of photosensitizers
Generation Photosensitizers
First generation Photofrin, hematoporphyrin derivatives
(HPDs)
Second generation 5-aminolevulinic acid (ALA),
benzoporphyrin derivative (BPD),
lutetium texaphyrin, temoporfin
(mTHPC), tinethyletiopurpurin
(SnET2), talaporfin sodium (LS11) and
Foscan® (mTHPC)
Third generation Biologic conjugates (e.g. Antibody
conjugate, liposome conjugate)
Table 1: Types of photosensitizers
Photosensitizers Examples
Phenothiazine dyes Methylene blue (MB) and toluidine
Blue O (TBO; Tolonium chloride)
Phthalocyanine dyes Aluminum disulphonated
phthalocyanine, cationic Zn(II)-
phthalocyanine, naphthalocyanine
Chlorophyll platform Chlorins_Purpurins_Bacteriochlorins
Porphyrins HPD (hematoporphyrin derivative),
Photofrin® and ALA (5-aminolevulinic
acid), texaphyrins, BPD
(benzoporphyrin derivative)
Xanthenes Erythrosin
Monoterpene Azulene
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parameters like probing depth, clinical attachment level and
bleeding on probing and showed clinically significant
improvement in all parameters using photodynamic therapy
as an adjunct to scaling and root planing.29-32
As an Adjunct to Periimplantitis
Periimplantitis is described as destructive inflammatory
process affecting the soft and hard tissues around osseo-
integrated implants, leading to the formation of a peri-implant
pocket and loss of supporting bone (1st European Workshop
on Periodontology, Ittingen, Switzerland, 1993).33
Conventional mechanical methods are apparently
ineffective for complete debridement of the bone defect as
well as of the contaminated microstructured implant surface.34
 Due to unfavorable periimplant tissue morphology after
therapy, implant surfaces exposed to bacterial contamination
sometimes cannot be kept plaque free by the patient with
conventional means of oral hygiene.34
Antimicrobial photodynamic therapy overcomes the
difficulties and problems of conventional antimicrobial
therapy and work as an adjunctive to conventional
periodontal therapy.
However, in vivo and clinical studies are very limited
and significant clinical effects of antimicrobial photodynamic
therapy have not yet been demonstrated28 (Tables 4 and 5).
From our limited clinical experience, adjunctive
application of antimicrobial photodynamic therapy during
nonsurgical treatment of periimplantitis did not provide
significant clinical improvements. Therefore, further animal
and clinical studies to establish the optimal conditions and
procedures for antimicrobial photodynamic therapy in the
nonsurgical or surgical treatment of periimplantitis, and to
demonstrate the advantages of antimicrobial photodynamic
therapy overconventional chemical methods for implant
surface decontamination, should be encouraged.
Disadvantages of Photodynamic Therapy
In photodynamic therapy, Laser power employed is very
low. But during treatment procedures, irradiation of the
patient’s eyes must be avoided by wearing protective glasses.
Most of the dyes adhere strongly to the soft tissue surface
of the pocket, and retention of the dyes in the pocket, even
for a short period of time, may affect periodontal tissue
attachment during wound healing.34
Current Status of Antimicrobial Photodynamic
Therapy and What is its Future
With combination of dyes and light application regarding
clinical application, whilst the manufacturer recommends
that antimicrobial photodynamic therapy treatment should
be performed repeatedly during the first week of healing to
enhance the antimicrobial effect. Some says single
application for example; the new periowave photo-
disinfection technology is a simple two-step clinical
procedure, which, within 60 seconds, destroys the cells of
specifically targeted Gram-negative anaerobic micro-
organisms in a selected periodontal defect.35,36
 While others says multiple application which, within
60 seconds gives better results, however, it has not been
established how often photodynamic therapy should be
applied for the effective elimination of bacteria, as well as
prevention of recolonization by the bacteria of sites
previously treated by nonsurgical periodontal therapy.37
Future studies are needed to elucidate, if multiple courses
of antimicrobial photodynamic therapy may enhance
treatment outcomes.
CONCLUSION
Antimicrobial photodynamic therapy seems to be a unique
and interesting therapeutic approach toward the treatment
of periodontitis and periimplantitis. However, the
wavelengths of diode lasers exhibiting deep-tissue
penetration basically do not interact with the periodontal
tissues within the pocket or tooth crown. Therefore,
photodynamic therapy as a low-level therapy, using a diode
laser with a short irradiation time, is considered not to
produce any thermal changes within the gingival tissues and
root surfaces, or destruction of the intact attachment
apparatus at the base of pockets. Furthermore, the liquid of
the photosensitizer solution applied may minimize thermal
generation within the pockets. However, an extended period
of irradiation at the same spot must be avoided to prevent
any thermal accumulation or injury to the deeper tissues,
such as bone or dental pulp. Thus, in order for lasers to be
used safely within the clinical environment, the practitioner
should have precise knowledge of the characteristics and
effects of the laser system and its performance during
application, and should exercise appropriate caution during
use.
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